Company Filing History:
Years Active: 2008
Title: Yasuhiro Kita: Innovator in Phosphatase Inhibitor Evaluation
Introduction
Yasuhiro Kita is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of biochemistry, particularly in the evaluation of phosphatase inhibitors. His work has implications for understanding and treating memory disorders and neurodegenerative diseases.
Latest Patents
Yasuhiro Kita holds a patent for "Methods of evaluating phosphatase inhibitors." This invention identifies OVARC1000473 (SEQ ID NO: 1) and NT2RM1000377 (SEQ ID NO: 3) as clones that suppress CREB activation by forskolin. The evaluation methods provided by this invention utilize these genes and/or the proteins they encode. Furthermore, the proteins were found to enhance cell damage. Compounds that can be screened based on these evaluation methods are useful as agents for inhibiting the CREB dephosphorylation reaction, suppressing cell damage enhancement, and serving as preventive and therapeutic agents for memory disorders and neurodegenerative disorders. Yasuhiro Kita has 1 patent to his name.
Career Highlights
Yasuhiro Kita is associated with Astellas Pharma GmbH, where he continues to contribute to innovative research in pharmaceuticals. His work is pivotal in advancing the understanding of phosphatase inhibitors and their potential therapeutic applications.
Collaborations
Yasuhiro has collaborated with notable colleagues, including Masahiko Morita and Hiroyuki Arakawa. Their combined expertise enhances the research efforts in their field.
Conclusion
Yasuhiro Kita's innovative work in evaluating phosphatase inhibitors showcases his commitment to advancing medical science. His contributions are vital for developing new therapeutic strategies for complex disorders.